์ฃผ์š” ์ฝ˜ํ…์ธ ๋กœ ๊ฑด๋„ˆ๋›ฐ๊ธฐ
  • ๋กœ๊ทธ์ธ
    ํ™˜์˜ํ•ฉ๋‹ˆ๋‹ค!
    ๋‚ด ๊ณ„์ •
    ๋กœ๊ทธ์•„์›ƒ

Elevation Oncology, Inc. (ELEV) ์ฃผ์‹ ์˜ˆ์ธก 2025 - AI ๊ฐ€๊ฒฉ ์˜ˆ์ธก ๋ฐ ๋ถ„์„

Elevation Oncology, Inc. (ELEV) AI ์ฃผ๊ฐ€ ์˜ˆ์ธก ๋ฐ ํˆฌ์ž ๋ถ„์„

Elevation Oncology, Inc. ์ฃผ๊ฐ€ ์ฐจํŠธ ๋ฐ ๊ธฐ์ˆ ์  ๋ถ„์„

Elevation Oncology, Inc. ๋Œ€ํ™”ํ˜• ๊ฐ€๊ฒฉ ์ฐจํŠธ ๋ฐ ๊ธฐ์ˆ  ๋ถ„์„ ๋กœ๋“œ ์ค‘...

Elevation Oncology, Inc. (ELEV) - ์ข…ํ•ฉ์ ์ธ ์ฃผ์‹ ๋ถ„์„ ๋ฐ ํˆฌ์ž ๋ฆฌ์„œ์น˜

Deep dive into Elevation Oncology, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Elevation Oncology, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ: Elevation Oncology, Inc. operates in the Life Sciences sector, making it an emerging small-cap investment.

Elevation Oncology, Inc. (์ฃผ์‹ ๊ธฐํ˜ธ: ELEV) ๋Š” Life Sciences ๋ถ€๋ฌธ์˜ ์„ ๋„ ๊ธฐ์—…์ž…๋‹ˆ๋‹ค. ํŠนํžˆ Biological Products, (No Diagnostic Substances) ์‚ฐ์—… ๋‚ด์—์„œ ์šด์˜๋ฉ๋‹ˆ๋‹ค..

์ „ ์„ธ๊ณ„ ์•ฝ 34๋ช…์˜ ์ „๋ฌธ๊ฐ€๋ฅผ ๊ณ ์šฉํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. .

ํšŒ์‚ฌ ๋กœ ์ž๋ฆฌ๋งค๊น€ํ–ˆ์Šต๋‹ˆ๋‹ค. ์ƒ๋‹นํ•œ ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์„ ๊ฐ€์ง„ ์ƒˆ๋กœ์šด ํˆฌ์ž ๊ธฐํšŒ.

Understanding Financial Performance

์ด๋Ÿฌํ•œ ๋ฉ”ํŠธ๋ฆญ์˜ ์˜๋ฏธ: Key financial indicators showing Elevation Oncology, Inc.'s revenue scale, profitability, market value, and shareholder returns.

์ฝ๋Š” ๋ฐฉ๋ฒ•: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ:

์‹œ๊ฐ€์ด์•ก: $22 ๋ฐฑ๋งŒ - ๋กœ ๋ถ„๋ฅ˜ ๋†’์€ ์„ฑ์žฅ ์ž ์žฌ๋ ฅ์„ ์ œ๊ณตํ•˜๋Š” ์†Œํ˜•์ฃผ ํˆฌ์ž.

์ž๊ธฐ์ž๋ณธ ์ˆ˜์ต๋ฅ (ROE): -92.4% - ํ‰๊ท  ์ดํ•˜ ์ฃผ์ฃผ ํ™˜์› ํšจ์œจ์„ฑ์„ ๋‚˜ํƒ€๋‚ด๋Š” ์šด์˜ ๊ฐœ์„ ์ด ํ•„์š”ํ•œ ์˜์—ญ.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Elevation Oncology, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ: Unlock premium access to view detailed AI predictions and price targets.

๐Ÿš€ ํ”„๋ฆฌ๋ฏธ์—„ AI ์˜ˆ์ธก ๊ธฐ๋Šฅ ์ž ๊ธˆ ํ•ด์ œ ๋ฅผ ํด๋ฆญํ•˜๋ฉด 7์ผ, 30์ผ, 90์ผ ๊ฐ€๊ฒฉ ๋ชฉํ‘œ์™€ ์‹ ๋ขฐ ๊ตฌ๊ฐ„ ๋ฐ ์œ„ํ—˜ ํ‰๊ฐ€๋ฅผ ํฌํ•จํ•œ Elevation Oncology, Inc. ์ฃผ์‹์— ๋Œ€ํ•œ ๊ณ ๊ธ‰ ๋จธ์‹  ๋Ÿฌ๋‹ ์˜ˆ์ธก์— ์•ก์„ธ์Šคํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Understanding Market Position

What this analysis covers: Elevation Oncology, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ: Market positioning analysis based on available financial and operational metrics.

Elevation Oncology, Inc.๋Š” ๋งค์šฐ ์—ญ๋™์ ์ธ ํ™˜๊ฒฝ์—์„œ ์ „๋žต์ ์œผ๋กœ ๊ฒฝ์Ÿํ•ฉ๋‹ˆ๋‹ค. Biological Products, (No Diagnostic Substances) ๋งˆ์ผ“ํ”Œ๋ ˆ์ด์Šค, ์ƒ๋‹นํ•œ ์„ฑ์žฅ ์ž ์žฌ๋ ฅ๊ณผ ์‹œ์žฅ ํŒŒ๊ดด์  ์—ญ๋Ÿ‰์„ ๊ฐ–์ถ˜ ์‹ ํฅ ์†Œํ˜•์ฃผ ํˆฌ์ž๋ฅผ ๋Œ€ํ‘œํ•ฉ๋‹ˆ๋‹ค. .

Elevation Oncology, Inc. (ELEV) ๊ธฐ๋ณธ ๋ถ„์„ ๋ฐ ๋‚ด๋ถ€์ž ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ (๋ถ„๊ธฐ๋ณ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ)

๋‹ค์Œ์— ๋Œ€ํ•œ ์ข…ํ•ฉ์ ์ธ ๋ถ„๊ธฐ๋ณ„ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ, ์ˆ˜์ต ๋™ํ–ฅ, ๋‚ด๋ถ€์ž ๊ฑฐ๋ž˜ ๋ฐ ๊ธฐ๊ด€ ๋ณด์œ  ํ˜„ํ™ฉ์„ ํ™•์ธํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. Elevation Oncology, Inc. ์ฃผ์‹ ๋ถ„์„.

์ข…ํ•ฉ ํŽ€๋”๋ฉ˜ํ„ธ ๋ถ„์„ ๋ฐ ๋‚ด๋ถ€์ž ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ Elevation Oncology, Inc. ๋กœ๋“œ ์ค‘...

Elevation Oncology, Inc.์˜ ์žฌ๋ฌด ์ƒํƒœ, ๊ฐ€์น˜ ํ‰๊ฐ€ ์ง€ํ‘œ, ์šด์˜ ํšจ์œจ์„ฑ์„ ์ž์„ธํžˆ ์‚ดํŽด๋ณด๊ณ  ์ •๋ณด์— ์ž…๊ฐํ•œ ํˆฌ์ž ๊ฒฐ์ •์„ ๋‚ด๋ฆฌ์„ธ์š”.

๊ฐ€์น˜ ํ‰๊ฐ€ ์ง€ํ‘œ ์ดํ•ด

์ด๋Ÿฌํ•œ ๋ฉ”ํŠธ๋ฆญ์˜ ์˜๋ฏธ: ๊ฐ€์น˜ ํ‰๊ฐ€ ์ง€ํ‘œ๋Š” Elevation Oncology, Inc. ์ฃผ์‹์ด ์ˆ˜์ต, ์ž์‚ฐ ๋ฐ ์‹œ์žฅ ํฌ์ง€์…˜์— ๋น„ํ•ด ๊ณต์ •ํ•œ ๊ฐ€๊ฒฉ์ธ์ง€ ํŒ๋‹จํ•˜๋Š” ๋ฐ ๋„์›€์ด ๋ฉ๋‹ˆ๋‹ค.

์ฝ๋Š” ๋ฐฉ๋ฒ•: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ: P/E ๋น„์œจ์ด -0.96์ธ ๊ฒฝ์šฐ, ์‹œ์žฅ ์ฃผ์‹์ด ์ž ์žฌ์ ์œผ๋กœ ์ €ํ‰๊ฐ€๋˜์—ˆ๋‹ค๊ณ  ํŒ๋‹จํ•˜๋Š” ๊ฒฝ์šฐ.

P/E Ratio -0.96x
P/B Ratio 0.48x
Market Cap $22M
EPS $-0.64
์žฅ๋ถ€๊ฐ€/์ฃผ์‹ $0.79
์ˆ˜์ต์„ฑ ์ง€ํ‘œ ์ดํ•ด

์ด๋Ÿฌํ•œ ๋ฉ”ํŠธ๋ฆญ์˜ ์˜๋ฏธ: ์ด ๋น„์œจ์€ Elevation Oncology, Inc.๊ฐ€ ์–ผ๋งˆ๋‚˜ ํšจ์œจ์ ์œผ๋กœ ์ˆ˜์ต์„ ์ˆ˜์ต์œผ๋กœ ์ „ํ™˜ํ•˜๊ณ  ์ฃผ์ฃผ์—๊ฒŒ ์ˆ˜์ต์„ ์ฐฝ์ถœํ•˜๋Š”์ง€๋ฅผ ์ธก์ •ํ•ฉ๋‹ˆ๋‹ค.

์ฝ๋Š” ๋ฐฉ๋ฒ•: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ: ROE -92.4% ์—์„œ ๊ฐœ์„ ์˜ ์—ฌ์ง€๊ฐ€ ์žˆ์Œ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค. ์ฃผ์ฃผ ๊ฐ€์น˜ ์ฐฝ์ถœ.

ROE -92.4%
ROA -42.9%
ROIC -92.4%
์žฌ๋ฌด ์ƒํƒœ ์ง€ํ‘œ ์ดํ•ด

์ด๋Ÿฌํ•œ ๋ฉ”ํŠธ๋ฆญ์˜ ์˜๋ฏธ: ์ด ๋น„์œจ์€ Elevation Oncology, Inc.๊ฐ€ ๋‹จ๊ธฐ ์˜๋ฌด๋ฅผ ์ดํ–‰ํ•˜๊ณ  ๋ถ€์ฑ„ ์ˆ˜์ค€์„ ํšจ๊ณผ์ ์œผ๋กœ ๊ด€๋ฆฌํ•  ์ˆ˜ ์žˆ๋Š” ๋Šฅ๋ ฅ์„ ํ‰๊ฐ€ํ•ฉ๋‹ˆ๋‹ค.

์ฝ๋Š” ๋ฐฉ๋ฒ•: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ: ํ˜„์žฌ ๋น„์œจ์€ 12.87์ž…๋‹ˆ๋‹ค. ๋Š” ๊ฐ•ํ•œ ์œ ๋™์„ฑ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค..

Current Ratio 12.87x
Quick Ratio 12.66x
Financial Leverage 1.08x
Working Capital $74M
ํ˜„๊ธˆ ํ๋ฆ„ ์ง€ํ‘œ ์ดํ•ด

์ด๋Ÿฌํ•œ ๋ฉ”ํŠธ๋ฆญ์˜ ์˜๋ฏธ: ํ˜„๊ธˆ ํ๋ฆ„ ๋ฉ”ํŠธ๋ฆญ์€ Elevation Oncology, Inc.์˜ ์šด์˜ ํ˜„๊ธˆ ์ฐฝ์ถœ ๋Šฅ๋ ฅ๊ณผ ์„ฑ์žฅ ์ด๋‹ˆ์…”ํ‹ฐ๋ธŒ์— ๋Œ€ํ•œ ์ž๊ธˆ ์กฐ๋‹ฌ ๋Šฅ๋ ฅ์„ ๋ณด์—ฌ์ค๋‹ˆ๋‹ค.

์ฝ๋Š” ๋ฐฉ๋ฒ•: ๊ธ์ •์ ์ธ ์˜์—… ํ˜„๊ธˆ ํ๋ฆ„์€ ๋งค์šฐ ์ค‘์š”ํ•ฉ๋‹ˆ๋‹ค. ์ž‰์—ฌ ํ˜„๊ธˆ ํ๋ฆ„์€ ๋ฐฐ๋‹น, ํ™˜๋งค ๋˜๋Š” ํˆฌ์ž์— ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ๋Š” ์ž๊ธˆ์„ ๋ณด์—ฌ์ค๋‹ˆ๋‹ค.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ: ์ž‰์—ฌํ˜„๊ธˆํ๋ฆ„ $-35M ์ฃผ์˜๊ฐ€ ํ•„์š”ํ•œ ํ˜„๊ธˆ ๋ฌธ์ œ๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค..

Operating Cash Flow $-35M
Free Cash Flow $-35M
์šด์˜ ํšจ์œจ์„ฑ ์ง€ํ‘œ์— ๋Œ€ํ•œ ์ดํ•ด

์ด๋Ÿฌํ•œ ๋ฉ”ํŠธ๋ฆญ์˜ ์˜๋ฏธ: ์ด ๋น„์œจ์€ Elevation Oncology, Inc.๊ฐ€ ์ž์‚ฐ์„ ์–ผ๋งˆ๋‚˜ ํšจ๊ณผ์ ์œผ๋กœ ์‚ฌ์šฉํ•˜๊ณ  ์šด์ „ ์ž๋ณธ์„ ๊ด€๋ฆฌํ•˜๋Š”์ง€๋ฅผ ์ธก์ •ํ•ฉ๋‹ˆ๋‹ค.

์ฝ๋Š” ๋ฐฉ๋ฒ•: ํšŒ์ „์œจ์ด ๋†’์„์ˆ˜๋ก ์ž์‚ฐ ํ™œ์šฉ์ด ํšจ์œจ์ ์ด๋ผ๋Š” ๋œป์ž…๋‹ˆ๋‹ค. ํšŒ์ˆ˜ ๊ธฐ๊ฐ„์ด ์งง์„์ˆ˜๋ก ํšจ๊ณผ์ ์ธ ์‹ ์šฉ ๊ด€๋ฆฌ๊ฐ€ ์ด๋ฃจ์–ด์ง€๊ณ  ์žˆ์Œ์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ:

์žฌ๋ฌด ์ œํ‘œ ๋ฐ์ดํ„ฐ ์ดํ•ด

์ด๋Ÿฌํ•œ ๋ฉ”ํŠธ๋ฆญ์˜ ์˜๋ฏธ: ์ ˆ๋Œ€ ์žฌ๋ฌด ์„ฑ๊ณผ๋ฅผ ๋ณด์—ฌ์ฃผ๋Š” Elevation Oncology, Inc.์˜ ์†์ต ๊ณ„์‚ฐ์„œ ๋ฐ ๋Œ€์ฐจ ๋Œ€์กฐํ‘œ์˜ ์ฃผ์š” ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.

์ฝ๋Š” ๋ฐฉ๋ฒ•: ์ˆ˜์ต์€ ์‚ฌ์—… ๊ทœ๋ชจ๋ฅผ ๋‚˜ํƒ€๋‚ด๊ณ  ๋งˆ์ง„์€ ์ˆ˜์ต์„ฑ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค. ๋Œ€์ฐจ ๋Œ€์กฐํ‘œ ํ•ญ๋ชฉ์€ ์žฌ๋ฌด ๊ตฌ์กฐ๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.

Elevation Oncology, Inc.์˜ ๊ฒฝ์šฐ:

์†์ต ๊ณ„์‚ฐ์„œ ($ ์ˆ˜๋ฐฑ๋งŒ)
์˜์—… ์ด์ต $-42M
์ˆœ์ด์ต $-41M
R&D ๋น„์šฉ $27M
๋Œ€์ฐจ ๋Œ€์กฐํ‘œ ์ฃผ์š” ๋‚ด์šฉ (% Of Assets)
Total Current Assets 100%
Cash & Short-term Investments 98%
Total Liabilities 8%
๋ฐฐ๋‹น๊ธˆ ๋ฐ ์ฃผ์ฃผ ์ •๋ณด
Shares Outstanding 59M
์„ฑ์žฅ ์ง€ํ‘œ(์ „๋…„ ๋Œ€๋น„)
EPS Growth -95.2%

์ตœ์‹  Elevation Oncology, Inc. ์ฃผ์‹ ๋‰ด์Šค ๋ฐ ์‹œ์žฅ ๋ถ„์„

Elevation Oncology, Inc. (ELEV) ์ฃผ๊ฐ€ ๋ฐ ํˆฌ์ž ์ „๋ง์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ์†๋ณด, ์• ๋„๋ฆฌ์ŠคํŠธ ๋ณด๊ณ ์„œ ๋ฐ ์‹œ์žฅ ์—…๋ฐ์ดํŠธ.

Elevation Oncology, Inc. ๊ฒฝ์Ÿ์‚ฌ ๋ฐ ๋™์ข…์—…๊ณ„ ๋ถ„์„ - Life Sciences ์„นํ„ฐ

AI ๊ธฐ๋ฐ˜ ์˜ˆ์ธก๊ณผ ์ฃผ์š” ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ํ†ตํ•ด Life Sciences ๋ถ€๋ฌธ์˜ ์—…๊ณ„ ๋™๋ฃŒ ๋ฐ ๊ฒฝ์Ÿ์‚ฌ์™€ Elevation Oncology, Inc.์„ ๋น„๊ต ๋ถ„์„ํ•ฉ๋‹ˆ๋‹ค.

ํšŒ์‚ฌ ํ‹ฐ์ปค ๊ธฐํ˜ธ 90์ผ AI ์˜ˆ๋ณด ์‹œ๊ฐ€์ด์•ก(USD M) P/E ๋น„์œจ P/B ๋น„์œจ
ABOS Unlock Forecast - 30 Days FREE Trial $85M -1.9x 0.7x
ABP Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ABPWW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ACLX Unlock Forecast - 30 Days FREE Trial $3725M -74.1x 8.9x
ACOG Unlock Forecast - 30 Days FREE Trial $143M x 4.5x
ADAP Unlock Forecast - 30 Days FREE Trial $65M -13.2x -11.8x
ADMA Unlock Forecast - 30 Days FREE Trial $4035M 19.3x 10.1x
ADPT Unlock Forecast - 30 Days FREE Trial $1901M -4.6x 10.6x
ADVM Unlock Forecast - 30 Days FREE Trial $58M -1.8x 2.2x
AGEN Unlock Forecast - 30 Days FREE Trial $130M -0.5x -0.5x
AIM Unlock Forecast - 30 Days FREE Trial $2M -0.5x -183.3x
AIMI Unlock Forecast - 30 Days FREE Trial $2M x x
ALEC Unlock Forecast - 30 Days FREE Trial $305M -1.2x 4.3x
ALGS Unlock Forecast - 30 Days FREE Trial $107M -19.2x 1.1x
ALLO Unlock Forecast - 30 Days FREE Trial $253M -1.4x 0.7x
ALVR Unlock Forecast - 30 Days FREE Trial $49M -0.5x 0.4x
AMGN Unlock Forecast - 30 Days FREE Trial $151464M 22.9x 20.4x
APGE Unlock Forecast - 30 Days FREE Trial $2240M -20.5x 4.3x
APTO Unlock Forecast - 30 Days FREE Trial $6M 0.0x -1.3x
APTOF Unlock Forecast - 30 Days FREE Trial $3M x x
ARMP Unlock Forecast - 30 Days FREE Trial $103M -1.0x -1.6x
ARTV Unlock Forecast - 30 Days FREE Trial $88M x 0.6x
ATHA Unlock Forecast - 30 Days FREE Trial $15M -0.2x 0.5x
ATRA Unlock Forecast - 30 Days FREE Trial $149M 25.8x -1.1x
ATYR Unlock Forecast - 30 Days FREE Trial $515M -3.6x 6.9x
AURA Unlock Forecast - 30 Days FREE Trial $402M -4.9x 2.3x
AUTL Unlock Forecast - 30 Days FREE Trial $389M x 1.1x
AVXL Unlock Forecast - 30 Days FREE Trial $876M -17.3x 9.6x
BCAB Unlock Forecast - 30 Days FREE Trial $125M -1.1x 1.0x
BCDA Unlock Forecast - 30 Days FREE Trial $12M -0.6x -7.8x
BCLI Unlock Forecast - 30 Days FREE Trial $7M -4.9x -0.9x
BCRX Unlock Forecast - 30 Days FREE Trial $1802M -12.1x -4.0x
BDTX Unlock Forecast - 30 Days FREE Trial $171M 11.8x 1.3x
BEAM Unlock Forecast - 30 Days FREE Trial $1979M -12.6x 1.9x
BIIB Unlock Forecast - 30 Days FREE Trial $18125M 12.8x 1.5x
BKHA Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BKHAU Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BLUE Unlock Forecast - 30 Days FREE Trial $49M -0.2x -0.8x
CABA Unlock Forecast - 30 Days FREE Trial $155M -1.6x 0.9x
CADL Unlock Forecast - 30 Days FREE Trial $338M -4.6x 4.5x
CCCC Unlock Forecast - 30 Days FREE Trial $193M -2.6x 1.1x
CDTX Unlock Forecast - 30 Days FREE Trial $728M -1.0x 5.1x
CELZ Unlock Forecast - 30 Days FREE Trial $9M -3.4x 1.3x
CERO Unlock Forecast - 30 Days FREE Trial $2M x -196.2x
CEROW Unlock Forecast - 30 Days FREE Trial $2M x -0.5x
CGEM Unlock Forecast - 30 Days FREE Trial $449M -4.1x 0.8x
CGEN Unlock Forecast - 30 Days FREE Trial $134M x 2.7x
CGON Unlock Forecast - 30 Days FREE Trial $2502M x 3.7x
CGTX Unlock Forecast - 30 Days FREE Trial $170M -0.5x 24.1x
CHRO Unlock Forecast - 30 Days FREE Trial $8M x -2.0x
CHRS Unlock Forecast - 30 Days FREE Trial $150M 0.8x 1.3x
CLDI Unlock Forecast - 30 Days FREE Trial $5M -0.9x 3.1x
CMPX Unlock Forecast - 30 Days FREE Trial $483M -4.8x 5.2x
COEPW Unlock Forecast - 30 Days FREE Trial $M x x
CRBU Unlock Forecast - 30 Days FREE Trial $174M -1.5x 1.1x
CRDF Unlock Forecast - 30 Days FREE Trial $144M -4.0x 2.5x
CRGX Unlock Forecast - 30 Days FREE Trial $215M x 0.9x
CRIS Unlock Forecast - 30 Days FREE Trial $18M -0.3x -2.9x
CRSP Unlock Forecast - 30 Days FREE Trial $4781M -12.1x 2.8x
CSBR Unlock Forecast - 30 Days FREE Trial $111M -17.8x 20.4x
CVM Unlock Forecast - 30 Days FREE Trial $56M -0.9x 8.0x
CYTH Unlock Forecast - 30 Days FREE Trial $26M -0.6x -1.9x
CYTHW Unlock Forecast - 30 Days FREE Trial $7M x -0.5x
DBVT Unlock Forecast - 30 Days FREE Trial $1479M -3.3x 514.8x
DNA Unlock Forecast - 30 Days FREE Trial $568M -13.9x 0.3x
DNLI Unlock Forecast - 30 Days FREE Trial $2111M -8.7x 1.9x
DTIL Unlock Forecast - 30 Days FREE Trial $59M -2.2x 1.7x
DYAI Unlock Forecast - 30 Days FREE Trial $28M -7.3x 11.4x
EDIT Unlock Forecast - 30 Days FREE Trial $231M -0.8x 3.7x
ELEV Unlock Forecast - 30 Days FREE Trial $22M -1.0x 0.5x
ELUT Unlock Forecast - 30 Days FREE Trial $84M -1.4x -0.1x
ENGN Unlock Forecast - 30 Days FREE Trial $276M 3.7x 1.2x
ENGNW Unlock Forecast - 30 Days FREE Trial $37M x 0.1x
ENTX Unlock Forecast - 30 Days FREE Trial $94M 8.5x 5.4x
ENZ Unlock Forecast - 30 Days FREE Trial $25M -3.0x 0.5x
ENZB Unlock Forecast - 30 Days FREE Trial $37M x 0.8x
ESLA Unlock Forecast - 30 Days FREE Trial $39M -3.1x -16.9x
ESLAW Unlock Forecast - 30 Days FREE Trial $4M x 5.3x
EXEL Unlock Forecast - 30 Days FREE Trial $10790M 17.9x 5.3x
EXOZ Unlock Forecast - 30 Days FREE Trial $100M x 13.9x
FATE Unlock Forecast - 30 Days FREE Trial $115M -1.3x 0.4x
FDMT Unlock Forecast - 30 Days FREE Trial $406M -3.0x 1.0x
FENC Unlock Forecast - 30 Days FREE Trial $250M 1758.3x -39.7x
FNCH Unlock Forecast - 30 Days FREE Trial $20M -0.1x 1.4x
FTII Unlock Forecast - 30 Days FREE Trial $-26M x -0.7x
FTIIU Unlock Forecast - 30 Days FREE Trial $-26M x -0.8x
FTIIW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
GILD Unlock Forecast - 30 Days FREE Trial $145510M 23.1x 7.4x
GLUE Unlock Forecast - 30 Days FREE Trial $398M 16.5x 1.5x
GNTA Unlock Forecast - 30 Days FREE Trial $64M x 5.1x
GPLB Unlock Forecast - 30 Days FREE Trial $M x x
HALO Unlock Forecast - 30 Days FREE Trial $9516M 17.1x 28.6x
HLVX Unlock Forecast - 30 Days FREE Trial $105M -0.6x 0.7x
HUMA Unlock Forecast - 30 Days FREE Trial $224M -3.3x 55.2x
HUMAW Unlock Forecast - 30 Days FREE Trial $163M x -2.6x
IBRX Unlock Forecast - 30 Days FREE Trial $2427M -3.6x -4.1x
IKNA Unlock Forecast - 30 Days FREE Trial $61M -1.3x 0.5x
IKT Unlock Forecast - 30 Days FREE Trial $150M -1.0x 1.9x
IMCR Unlock Forecast - 30 Days FREE Trial $1827M x 4.7x
IMVT Unlock Forecast - 30 Days FREE Trial $2803M -14.5x 4.6x
INAB Unlock Forecast - 30 Days FREE Trial $21M -0.4x 2.4x
INBX Unlock Forecast - 30 Days FREE Trial $436M -6.8x 6.4x
INKT Unlock Forecast - 30 Days FREE Trial $59M -1.5x -1.4x
INMB Unlock Forecast - 30 Days FREE Trial $52M -2.5x 1.8x
INTS Unlock Forecast - 30 Days FREE Trial $7M -2.2x 3.4x
IOVA Unlock Forecast - 30 Days FREE Trial $851M -4.5x 1.2x
IPSC Unlock Forecast - 30 Days FREE Trial $44M -0.7x 0.2x
ITOS Unlock Forecast - 30 Days FREE Trial $393M -2.8x 0.7x
IVVD Unlock Forecast - 30 Days FREE Trial $137M -0.4x 3.2x
IZTC Unlock Forecast - 30 Days FREE Trial $99M x -27.5x
JSPR Unlock Forecast - 30 Days FREE Trial $44M -3.2x 1.9x
JSPRW Unlock Forecast - 30 Days FREE Trial $3M x 0.0x
KLRS Unlock Forecast - 30 Days FREE Trial $86M x 1.6x
KLTO Unlock Forecast - 30 Days FREE Trial $26M x 2.4x
KLTOW Unlock Forecast - 30 Days FREE Trial $1M x 0.4x
KOD Unlock Forecast - 30 Days FREE Trial $556M -2.5x 7.9x
KRBPQ Unlock Forecast - 30 Days FREE Trial $0M x x
KRYS Unlock Forecast - 30 Days FREE Trial $4330M 29.5x 4.2x
KYMR Unlock Forecast - 30 Days FREE Trial $3533M -17.8x 3.6x
KYTX Unlock Forecast - 30 Days FREE Trial $170M x 0.9x
LADX Unlock Forecast - 30 Days FREE Trial $M x x
LCTX Unlock Forecast - 30 Days FREE Trial $271M -4.7x 5.6x
LENZ Unlock Forecast - 30 Days FREE Trial $1141M -6.7x 5.5x
LIMN Unlock Forecast - 30 Days FREE Trial $0M x x
LXEO Unlock Forecast - 30 Days FREE Trial $271M -0.4x 2.0x
MAZE Unlock Forecast - 30 Days FREE Trial $696M x 2.7x
MGTX Unlock Forecast - 30 Days FREE Trial $693M -3.4x 20.9x
MGX Unlock Forecast - 30 Days FREE Trial $72M x 0.4x
MRNA Unlock Forecast - 30 Days FREE Trial $9659M -3.2x 1.0x
NBIX Unlock Forecast - 30 Days FREE Trial $14639M 42.0x 5.4x
NKGN Unlock Forecast - 30 Days FREE Trial $4M -0.1x -0.2x
NKGNW Unlock Forecast - 30 Days FREE Trial $1M x 0.0x
NMRA Unlock Forecast - 30 Days FREE Trial $271M -3.9x 1.5x
NVAX Unlock Forecast - 30 Days FREE Trial $1417M 3.4x 37.7x
OCGN Unlock Forecast - 30 Days FREE Trial $298M -4.3x 18.7x
OMGA Unlock Forecast - 30 Days FREE Trial $9M -0.7x 0.8x
OMGAQ Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ONVO Unlock Forecast - 30 Days FREE Trial $35M -0.4x 95.9x
OTLK Unlock Forecast - 30 Days FREE Trial $73M -0.2x -2.3x
PALI Unlock Forecast - 30 Days FREE Trial $4M -0.2x 0.7x
PASG Unlock Forecast - 30 Days FREE Trial $23M -0.6x 0.6x
PCVX Unlock Forecast - 30 Days FREE Trial $4403M -20.4x 1.4x
PHGE Unlock Forecast - 30 Days FREE Trial $14M 1.5x 0.7x
PLUR Unlock Forecast - 30 Days FREE Trial $-4M -1.4x -9.1x
PLX Unlock Forecast - 30 Days FREE Trial $120M 19.1x 2.4x
PMCB Unlock Forecast - 30 Days FREE Trial $7M -2.6x 0.2x
PRME Unlock Forecast - 30 Days FREE Trial $500M -1.5x 8.2x
PROK Unlock Forecast - 30 Days FREE Trial $-62M x 0.0x
PSTX Unlock Forecast - 30 Days FREE Trial $926M -9.6x 10.6x
PTHS Unlock Forecast - 30 Days FREE Trial $M x x
QGEN Unlock Forecast - 30 Days FREE Trial $10692M x 3.0x
QNCX Unlock Forecast - 30 Days FREE Trial $86M -1.7x 7.4x
REPL Unlock Forecast - 30 Days FREE Trial $932M -3.8x 2.2x
RGEN Unlock Forecast - 30 Days FREE Trial $6531M 8219.1x 3.3x
RGNX Unlock Forecast - 30 Days FREE Trial $499M -1.8x 2.3x
RLAY Unlock Forecast - 30 Days FREE Trial $707M -2.0x 1.1x
RVMD Unlock Forecast - 30 Days FREE Trial $7134M -11.1x 3.4x
RVMDW Unlock Forecast - 30 Days FREE Trial $16M x 0.0x
RXRX Unlock Forecast - 30 Days FREE Trial $2019M -4.7x 2.2x
SABS Unlock Forecast - 30 Days FREE Trial $24M -2.3x 1.1x
SABSW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
SANA Unlock Forecast - 30 Days FREE Trial $719M -2.1x 5.9x
SCLX Unlock Forecast - 30 Days FREE Trial $62M -0.4x -0.3x
SCLXW Unlock Forecast - 30 Days FREE Trial $25M x -0.1x
SCNI Unlock Forecast - 30 Days FREE Trial $9674M -287.8x 1231.2x
SGMO Unlock Forecast - 30 Days FREE Trial $131M -1.6x 6.7x
SLDB Unlock Forecast - 30 Days FREE Trial $495M -0.9x 1.7x
SLXN Unlock Forecast - 30 Days FREE Trial $4M x 34.5x
SLXNW Unlock Forecast - 30 Days FREE Trial $866M x -189.1x
SNTI Unlock Forecast - 30 Days FREE Trial $51M -1.1x 1.3x
SRRK Unlock Forecast - 30 Days FREE Trial $4069M -18.5x 13.0x
SRZN Unlock Forecast - 30 Days FREE Trial $105M -0.5x 2.2x
SRZNW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
STRO Unlock Forecast - 30 Days FREE Trial $90M -1.0x -2.5x
SWTX Unlock Forecast - 30 Days FREE Trial $3539M -9.9x 8.5x
TARA Unlock Forecast - 30 Days FREE Trial $131M -2.1x 0.9x
TARS Unlock Forecast - 30 Days FREE Trial $2390M -12.4x 7.2x
TCBP Unlock Forecast - 30 Days FREE Trial $37M x 34.5x
TCBPW Unlock Forecast - 30 Days FREE Trial $1M x 1.0x
TCBPY Unlock Forecast - 30 Days FREE Trial $13M x 12.0x
TCRX Unlock Forecast - 30 Days FREE Trial $248M -4.6x 1.4x
TECH Unlock Forecast - 30 Days FREE Trial $8155M 75.2x 4.0x
TECX Unlock Forecast - 30 Days FREE Trial $314M -8.9x 1.1x
TIL Unlock Forecast - 30 Days FREE Trial $182M -1.1x 1.3x
TNYA Unlock Forecast - 30 Days FREE Trial $184M -2.5x 1.9x
TRML Unlock Forecast - 30 Days FREE Trial $688M -3.5x 2.7x
TSBX Unlock Forecast - 30 Days FREE Trial $8M -0.1x 0.6x
TSHA Unlock Forecast - 30 Days FREE Trial $919M -3.0x 3.7x
TTNP Unlock Forecast - 30 Days FREE Trial $8M -0.5x 4.5x
TVGN Unlock Forecast - 30 Days FREE Trial $168M x -29.3x
TVGNW Unlock Forecast - 30 Days FREE Trial $11M x -1.9x
TWST Unlock Forecast - 30 Days FREE Trial $1487M -12.6x 3.1x
VACH Unlock Forecast - 30 Days FREE Trial $-1436M x 0.0x
VACHU Unlock Forecast - 30 Days FREE Trial $-1585M x 0.0x
VCEL Unlock Forecast - 30 Days FREE Trial $1655M 232.9x 5.4x
VIGL Unlock Forecast - 30 Days FREE Trial $384M -1.1x 9.3x
VIR Unlock Forecast - 30 Days FREE Trial $732M -2.0x 0.8x
VIVS Unlock Forecast - 30 Days FREE Trial $3M x 0.3x
VOR Unlock Forecast - 30 Days FREE Trial $246M -0.6x 3.9x
VXRT Unlock Forecast - 30 Days FREE Trial $87M -0.9x 2.7x
VYGR Unlock Forecast - 30 Days FREE Trial $248M 570.6x 1.0x
WINT Unlock Forecast - 30 Days FREE Trial $18M -0.4x 4.2x
XFOR Unlock Forecast - 30 Days FREE Trial $8M 6.4x 0.4x
ZIVO Unlock Forecast - 30 Days FREE Trial $57M -31.3x -2.0x
ZURA Unlock Forecast - 30 Days FREE Trial $131M 5.0x 0.9x

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ - Elevation Oncology, Inc. ์žฌ๊ณ  ์˜ˆ์ธก

Elevation Oncology, Inc. ์ฃผ์‹ ์˜ˆ์ธก์€ ์–ผ๋งˆ๋‚˜ ์ •ํ™•ํ•ฉ๋‹ˆ๊นŒ?

Our AI model demonstrates 24% historical accuracy for ELEV predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

๋ณ€์ˆ˜_0__ ์ฃผ๊ฐ€ ์˜ˆ์ธก์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ์š”์ธ์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๋ถ„์„์—๋Š” Elevation Oncology, Inc.์˜ ์žฌ๋ฌด ์ง€ํ‘œ, Life Sciences ์„นํ„ฐ ๋™ํ–ฅ, ์‹œ์žฅ ์‹ฌ๋ฆฌ, ๊ธฐ์ˆ  ์ง€ํ‘œ, ์ˆ˜์ต ๋ฐ์ดํ„ฐ ๋ฐ ์ฃผ์‹ ์„ฑ๊ณผ์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๊ฑฐ์‹œ ๊ฒฝ์ œ ์š”์ธ์ด ๊ณ ๋ ค๋ฉ๋‹ˆ๋‹ค.

2025๋…„์— Elevation Oncology, Inc.์ด ์ข‹์€ ํˆฌ์ž์ธ๊ฐ€์š”?

AI ๋ถ„์„์— ๋”ฐ๋ฅด๋ฉด Elevation Oncology, Inc.๋Š” ๋‹ค์Œ์„ ๋ณด์—ฌ์ค๋‹ˆ๋‹ค. ๋‹ค์–‘ํ•œ ์‹œ์žฅ ์‹œ๋‚˜๋ฆฌ์˜ค์— ๋Œ€ํ•œ ์ž ์žฌ๋ ฅ. ํˆฌ์ž ๊ฒฐ์ •์„ ๋‚ด๋ฆฌ๊ธฐ ์ „์— ์ž์‹ ์˜ ์œ„ํ—˜ ๊ฐ๋‚ด ๋Šฅ๋ ฅ, ํˆฌ์ž ์ผ์ •, ํฌํŠธํด๋ฆฌ์˜ค ๋‹ค๊ฐํ™”๋ฅผ ๊ณ ๋ คํ•˜์„ธ์š”.

Elevation Oncology, Inc. ์˜ˆ์ธก์€ ์–ผ๋งˆ๋‚˜ ์ž์ฃผ ์—…๋ฐ์ดํŠธ๋˜๋‚˜์š”?

Elevation Oncology, Inc. ์ฃผ์‹ ์˜ˆ์ธก์€ ์‹ค์‹œ๊ฐ„ ์‹œ์žฅ ๋ฐ์ดํ„ฐ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋งค์ผ ์—…๋ฐ์ดํŠธ๋˜๋ฏ€๋กœ ์ตœ์‹  AI ๊ธฐ๋ฐ˜ ์˜ˆ์ธก๊ณผ ํˆฌ์ž ์ธ์‚ฌ์ดํŠธ๋ฅผ ๋ฐ›์•„๋ณผ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ณ ๊ธ‰ Elevation Oncology, Inc. ๋ถ„์„์„ ์›ํ•˜์‹œ๋‚˜์š”?

์ž์„ธํ•œ ๊ฐ€๊ฒฉ ๋ชฉํ‘œ, ์œ„ํ—˜ ํ‰๊ฐ€, ํฌํŠธํด๋ฆฌ์˜ค ์ตœ์ ํ™”, Elevation Oncology, Inc. ์ฃผ์‹์— ๋Œ€ํ•œ ์‹ค์‹œ๊ฐ„ ์•Œ๋ฆผ ๋“ฑ ํ”„๋ฆฌ๋ฏธ์—„ ๊ธฐ๋Šฅ์„ ์ž ๊ธˆ ํ•ด์ œํ•˜์„ธ์š”.

๐ŸŽฏ ํ”„๋ฆฌ๋ฏธ์—„ ๋ถ„์„ ๋ฐ›๊ธฐ ๐Ÿ“Š ๋” ๋งŽ์€ ์ฃผ์‹ ํƒ์ƒ‰

๋‚ด ํฌํŠธํด๋ฆฌ์˜ค

ํˆฌ์ž ๋Œ€์‹œ๋ณด๋“œ

ํฌํŠธํด๋ฆฌ์˜ค ๋กœ๋“œ ์ค‘...